Avior Wealth Management LLC cut its stake in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 14.9% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,143 shares of the technology company’s stock after selling 200 shares during the period. Avior Wealth Management LLC’s holdings in Amdocs were worth $100,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Catalyst Capital Advisors LLC purchased a new position in shares of Amdocs during the 3rd quarter valued at $55,000. GAMMA Investing LLC grew its stake in Amdocs by 115.1% in the third quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock valued at $70,000 after purchasing an additional 428 shares in the last quarter. American National Bank acquired a new position in Amdocs in the 2nd quarter worth about $76,000. Meeder Asset Management Inc. purchased a new stake in shares of Amdocs during the 3rd quarter worth about $77,000. Finally, Blue Trust Inc. raised its stake in shares of Amdocs by 18.0% during the 2nd quarter. Blue Trust Inc. now owns 1,138 shares of the technology company’s stock worth $90,000 after purchasing an additional 174 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.
Amdocs Stock Up 0.6 %
NASDAQ DOX opened at $85.67 on Friday. Amdocs Limited has a twelve month low of $74.41 and a twelve month high of $94.04. The stock has a market cap of $10.07 billion, a PE ratio of 20.21, a PEG ratio of 1.42 and a beta of 0.74. The firm has a 50-day simple moving average of $88.03 and a 200 day simple moving average of $83.96. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.24 and a current ratio of 1.20.
Amdocs Dividend Announcement
Analysts Set New Price Targets
DOX has been the subject of several recent research reports. Stifel Nicolaus began coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 target price for the company. Barclays decreased their price objective on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 14th. Finally, Oppenheimer upped their price target on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $101.83.
View Our Latest Stock Analysis on DOX
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories
- Five stocks we like better than Amdocs
- Why Invest in High-Yield Dividend Stocks?
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- How to Calculate Inflation Rate
- MarketBeat Week in Review – 11/18 – 11/22
- The Role Economic Reports Play in a Successful Investment Strategy
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.